EIB backs Akagera vaccine development
Early-stage vaccine development in Rwanda by Akagera Medicines Africa will be supported by €2 million financing from EIB. The new backing will...
Early-stage vaccine development in Rwanda by Akagera Medicines Africa will be supported by €2 million financing from EIB. The new backing will...